Reasons - Cup & handle formation - Bounces on trendline - Currently developing COVID-19 vaccine in Korea alongside other biotech products - Korean government granted $30 mil to develop vaccines recently
การซื้อขายยังคงดำเนินอยู่
Prices pulled back from the initial trendline due to choppiness from falling KOSDAQ index. This was due to fears of economic shutdown from COVID-19 breakouts.
Still a go. It still has not announced a clinical trial for the COVID-19 vaccine but received money from the Korean government to develop one. If it is announced, then it is going to rocket.